New York, May 7 (FinanceEnquiry.com) – Analyst Steven Silver of S&P Capital IQ reiterates his BUY rating on the shares of Vertex Pharmaceuticals (NASDAQ: VRTX). The target price has been raised from $44 to $62.
In a research note published this morning, the analyst mentions that Vertex Pharmaceuticals’ shares rose 44%, as the company reported interim Phase II data study of VX-809 and Kalydeco for cystic fibrosis patients with two copies of the common F508del mutation, showing statistically significant lung function improvements. The results (46% saw 5% improvement and 30% saw 10% improvement) are more robust than expected, with up to $3 billion of peak revenue potential, the analyst says. Vertex Pharmaceuticals’ shares, however, would remain volatile as the details of the full study are expected around mid-2012, while the program advances to Phase II study, the analyst adds.
New York, May 20 (FinanceEnquiry.com) – Seeing that investors expect China would put into use reforms in order to refresh slumping economy of the nation, Hong Kong shares soared to their uppermost level in 3-...Automobile Sales Ascend across Europe - May 17, 2013
New York, May 17 (FinanceEnquiry.com) – Being enhanced by healthy requirement in the UK, latest car sales across Europe soared in the earlier month for the initial time in 18 months. As compared with a year...Nikkei Rises on US expansion Optimisms; Watchfulness on Feeble Global Expansion Caps Asian Shares - May 7, 2013
New York, May 7 (FinanceEnquiry.com) – Even though refreshed anticipations for a stable US recovery drove Japanese equities to a near five-year crest, still Asian shares were capped on May 7 by warning...Deutsche Bank Securities Reiterates BUY Rating on Allegiant Travel Company (NASDAQ: ALGT), Target Price Raised - April 25, 2013
New York, April 17 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of Freeport-McMoRan Copper & Gold Inc (NYSE: FCX). The 12-month target price is set...Asian Shares Plunge, Commodities Drop; China Economic Expansion Eases Suddenly - April 15, 2013
New York, April 15 (FinanceEnquiry.com) – As soon as economic expansion of China all of a sudden eased in the 1Q with lower gains in factory-production, Asian stocks fell from the uppermost level in...US House Costs Soared in Feb by Biggest Amount In Seven Years - April 4, 2013
New York, April 4 (FinanceEnquiry.com) – Providing the proof that the housing improvement reinforced prior to the crucial spring-buying period, US house costs soared in the month of February by the biggest...Asian Shares and the Euro Plunge - April 1, 2013
New York, April 1 (FinanceEnquiry.com) – Asian shares and the euro skidded on the very first day of the month in uneven trade with exchanges closed in more than a few Asian markets, together with Australia...Deutsche Bank Securities Reiterates HOLD Rating on James River Coal Co (NASDAQ: JRCC), Target Price Reduced - March 11, 2013
New York, March 12 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their HOLD rating on the shares of James River Coal Co (NASDAQ: JRCC). The 12-month target price has been reduced to...